The Impact of Artificial Intelligence in the Odyssey of Rare Diseases
Author:
Affiliation:
1. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
2. Competence Center ARTES 4.0, 53100 Siena, Italy
3. SienabioACTIVE—SbA, 53100 Siena, Italy
Abstract
Publisher
MDPI AG
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Link
https://www.mdpi.com/2227-9059/11/3/887/pdf
Reference103 articles.
1. Challenges and Opportunities in The Treatment of Rare Diseases;Vickers;Drug Discov. World,2013
2. Drugs for exceptionally rare diseases: Do they deserve special status for funding?;Hughes;QJM Int. J. Med.,2005
3. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database;Lambert;Eur. J. Hum. Genet.,2020
4. European Union (2022, November 18). Regulation (EC) N°141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32000R0141.
5. National Institute of Health (2022, December 14). Public Law 97–414 97th Congress, Available online: https://www.govinfo.gov/content/pkg/STATUTE-96/pdf/STATUTE-96-Pg2049.pdf.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Artificial intelligence in cancer diagnosis: Opportunities and challenges;Pathology - Research and Practice;2024-01
2. Automatically pre-screening patients for the rare disease aromatic l-amino acid decarboxylase deficiency using knowledge engineering, natural language processing, and machine learning on a large EHR population;Journal of the American Medical Informatics Association;2023-12-22
3. Revolutionizing Biological Science: The Synergy of Genomics in Health, Bioinformatics, Agriculture, and Artificial Intelligence;OMICS: A Journal of Integrative Biology;2023-12-01
4. Applications of Artificial Intelligence in Microbial Diagnosis;Cureus;2023-11-24
5. A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score;Thrombosis Journal;2023-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3